BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25772233)

  • 1. Pregabalin for painful diabetic peripheral neuropathy: strategies for dosing, monotherapy vs. combination therapy, treatment-refractory patients, and adverse events.
    Juhn MS; Parsons B; Varvara R; Sadosky A
    Curr Med Res Opin; 2015 May; 31(5):1017-26. PubMed ID: 25772233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care costs in patients with painful diabetic peripheral neuropathy prescribed pregabalin or duloxetine.
    Burke JP; Sanchez RJ; Joshi AV; Cappelleri JC; Kulakodlu M; Halpern R
    Pain Pract; 2012 Mar; 12(3):209-18. PubMed ID: 21676163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial.
    Richter RW; Portenoy R; Sharma U; Lamoreaux L; Bockbrader H; Knapp LE
    J Pain; 2005 Apr; 6(4):253-60. PubMed ID: 15820913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with diabetic neuropathy newly prescribed pregabalin or gabapentin.
    Gore M; Tai KS; Zlateva G; Bala Chandran A; Leslie D
    Pain Pract; 2011; 11(6):528-39. PubMed ID: 21435162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of patients with painful diabetic peripheral neuropathy who have a favorable cost profile with pregabalin treatment.
    Udall M; Mardekian J; Cabrera J
    Pain Pract; 2013 Jul; 13(6):476-84. PubMed ID: 23150918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials.
    Roth T; van Seventer R; Murphy TK
    Curr Med Res Opin; 2010 Oct; 26(10):2411-9. PubMed ID: 20812792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost-utility comparison of four first-line medications in painful diabetic neuropathy.
    O'Connor AB; Noyes K; Holloway RG
    Pharmacoeconomics; 2008; 26(12):1045-64. PubMed ID: 19014205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial.
    Arezzo JC; Rosenstock J; Lamoreaux L; Pauer L
    BMC Neurol; 2008 Sep; 8():33. PubMed ID: 18796160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of pregabalin in patients with moderate and severe pain due to diabetic peripheral neuropathy.
    Parsons B; Li C
    Curr Med Res Opin; 2016 May; 32(5):929-37. PubMed ID: 26854578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An economic evaluation of pregabalin versus usual care in the management of community-treated patients with refractory painful diabetic peripheral neuropathy in primary care settings.
    de Salas-Cansado M; Pérez C; Saldaña MT; Navarro A; González-Gómez FJ; Ruiz L; Rejas J
    Prim Care Diabetes; 2012 Dec; 6(4):303-12. PubMed ID: 22595032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Curr Med Res Opin; 2009 Jul; 25(7):1677-87. PubMed ID: 19480610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective evaluation of clinical characteristics, pharmacotherapy and healthcare resource use among patients prescribed pregabalin or duloxetine for diabetic peripheral neuropathy in usual care.
    Gore M; Zlateva G; Tai KS; Chandran AB; Leslie D
    Pain Pract; 2011; 11(2):167-79. PubMed ID: 20723096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pregabalin in the treatment of neuropathic pain].
    Biegstraaten M; van Schaik IN
    Ned Tijdschr Geneeskd; 2007 Jul; 151(28):1561-5. PubMed ID: 17715763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
    Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ
    J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Responses to Pregabalin for Painful Diabetic Peripheral Neuropathy Based on Trajectory-Focused Patient Profiles Derived from the First 4 Weeks of Treatment.
    Edwards RA; Bonfanti G; Grugni R; Manca L; Parsons B; Alexander J
    Adv Ther; 2018 Oct; 35(10):1585-1597. PubMed ID: 30206821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose Titration of Pregabalin in Patients with Painful Diabetic Peripheral Neuropathy: Simulation Based on Observational Study Patients Enriched with Data from Randomized Studies.
    Alexander J; Edwards RA; Manca L; Grugni R; Bonfanti G; Emir B; Whalen E; Watt S; Parsons B
    Adv Ther; 2018 Mar; 35(3):382-394. PubMed ID: 29476444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis.
    van Nooten F; Treur M; Pantiri K; Stoker M; Charokopou M
    Clin Ther; 2017 Apr; 39(4):787-803.e18. PubMed ID: 28365034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain.
    Tesfaye S; Wilhelm S; Lledo A; Schacht A; Tölle T; Bouhassira D; Cruccu G; Skljarevski V; Freynhagen R
    Pain; 2013 Dec; 154(12):2616-2625. PubMed ID: 23732189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses.
    Freeman R; Durso-Decruz E; Emir B
    Diabetes Care; 2008 Jul; 31(7):1448-54. PubMed ID: 18356405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.